(NU/1433-40) Transdermal Drug Delivery: The Provision of Business Consultancy to Assist Commercialisation of University Research.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-039727-2023-01-13T10:29:42Z",
    "date": "2023-01-13T10:29:42Z",
    "ocid": "ocds-h6vhtk-039727",
    "initiationType": "tender",
    "tender": {
        "id": "DN638711",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "(NU/1433-40) Transdermal Drug Delivery: The Provision of Business Consultancy to Assist Commercialisation of University Research.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "79400000",
            "description": "Business and management consultancy and related services"
        },
        "mainProcurementCategory": "services",
        "description": "The Northumbria University team have developed a new technology to move drugs into the body from a layer in a patch stuck to the skin. This is an alternative to using needles. Current drug delivery patches don't work for a large proportion of drugs because of their chemistry characteristics mean they don't absorb through skin well. This technology can move 'difficult' molecules through the skin. The initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; a. Act for the company in the spin-out legal process and address all company formation matters; b. Provide to the appropriate university all matters necessary for Research England reporting requirements; (3) Secure a Medical Device Manufacturer partnership (4) Engage with investors in securing funding",
        "lots": [
            {
                "id": "1",
                "description": "The Northumbria University team have developed a new technology to move drugs into the body from a layer in a patch stuck to the skin. This is an alternative to using needles. Current drug delivery patches don't work for a large proportion of drugs because of their chemistry characteristics mean they don't absorb through skin well. This technology can move 'difficult' molecules through the skin. The initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; a. Act for the company in the spin-out legal process and address all company formation matters; b. Provide to the appropriate university all matters necessary for Research England reporting requirements; (3) Secure a Medical Device Manufacturer partnership (4) Engage with investors in securing funding",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "Ability to meet the required programme",
                            "type": "quality",
                            "description": "Pass/Fail"
                        },
                        {
                            "name": "Quality: Ability to meet the Job description",
                            "type": "quality",
                            "description": "Pass/Weighted and 60%"
                        },
                        {
                            "name": "Equity",
                            "type": "quality",
                            "description": "15%"
                        },
                        {
                            "type": "price",
                            "description": "25%"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKC"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "selective",
        "procurementMethodDetails": "Restricted procedure",
        "techniques": {
            "hasDynamicPurchasingSystem": true
        },
        "coveredBy": [
            "GPA"
        ],
        "reviewDetails": "The University will incorporate a standstill period at the point information on the award of the contract is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into. The Public Contracts Regulations 2015 (SI 2015 No 102) provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland) within 30 days of knowledge or constructive knowledge of breach."
    },
    "awards": [
        {
            "id": "001055-2023-(NU/1433-40)-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-72754",
                    "name": "Dr Peter Arnold"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-168",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "streetAddress": "Newcastle University, Procurement Services, Kingsgate",
                "locality": "Newcastle",
                "region": "UKC",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Mrs Natalie Morton",
                "telephone": "+44 1912086396",
                "email": "natalie.morton@ncl.ac.uk"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "url": "https://www.ncl.ac.uk",
                "buyerProfile": "https://www.ncl.ac.uk",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "09",
                        "description": "Education"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-172",
            "name": "European Union",
            "roles": [
                "funder"
            ]
        },
        {
            "id": "GB-FTS-72754",
            "name": "Dr Peter Arnold",
            "identifier": {
                "legalName": "Dr Peter Arnold"
            },
            "address": {
                "locality": "Chapel House, Shepherds Hill",
                "region": "UKC",
                "postalCode": "NE663NG",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-174",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "locality": "Tyne and Wear",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ]
        },
        {
            "id": "GB-FTS-72755",
            "name": "Newcastle University",
            "identifier": {
                "legalName": "Newcastle University"
            },
            "address": {
                "locality": "Newcastle University, Procurement Services, Kingsgate",
                "postalCode": "NE1 7RU",
                "countryName": "United Kingdom"
            },
            "roles": [
                "mediationBody",
                "reviewContactPoint"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-168",
        "name": "Newcastle University"
    },
    "planning": {
        "budget": {
            "finance": [
                {
                    "id": "1",
                    "description": "Northern Accelerator programme involving funding from both the European Regional Development Funding (ERDF) and Research England",
                    "financingParty": {
                        "name": "European Union",
                        "id": "GB-FTS-172"
                    },
                    "relatedLots": [
                        "1"
                    ]
                }
            ]
        }
    },
    "contracts": [
        {
            "id": "001055-2023-(NU/1433-40)-1",
            "awardID": "001055-2023-(NU/1433-40)-1",
            "status": "active",
            "value": {
                "amount": 30000,
                "currency": "GBP"
            },
            "dateSigned": "2022-12-19T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 3
            },
            {
                "id": "2",
                "measure": "smeBids",
                "relatedLot": "1",
                "value": 3
            },
            {
                "id": "3",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "1",
                "value": 3
            },
            {
                "id": "4",
                "measure": "electronicBids",
                "relatedLot": "1",
                "value": 3
            }
        ]
    },
    "links": [
        {
            "rel": "prev",
            "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:528050-2022:TEXT:EN:HTML"
        }
    ],
    "language": "en"
}